These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22309267)

  • 1. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T
    J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T
    J Microencapsul; 2012; 29(3):211-8. PubMed ID: 22360765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
    Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats.
    Obata H; Sakai Y; Ohnishi S; Takeshita S; Mori H; Kodama M; Kangawa K; Aizawa Y; Nagaya N
    Am J Respir Crit Care Med; 2008 Jan; 177(2):195-201. PubMed ID: 17975203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres.
    Uchida T; Hazekawa M; Morisaki T; Yoshida M; Sakai Y
    J Microencapsul; 2013; 30(3):245-56. PubMed ID: 23094609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension.
    Kataoka M; Nagaya N; Satoh T; Itoh T; Murakami S; Iwase T; Miyahara Y; Kyotani S; Sakai Y; Kangawa K; Ogawa S
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1575-80. PubMed ID: 16192456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury.
    Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M
    Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension.
    Nakamura A; Nagaya N; Obata H; Sakai K; Sakai Y; Yoshikawa M; Hamada K; Matsumoto K; Kimura H
    Circ J; 2013; 77(8):2127-33. PubMed ID: 23676973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
    Hasegawa Y; Morioka M; Hasegawa S; Matsumoto J; Kawano T; Kai Y; Yano S; Fukunaga K; Kuratsu J
    J Pharmacol Exp Ther; 2006 May; 317(2):875-81. PubMed ID: 16461588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
    Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
    Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
    Nakamura K; Sata M; Iwata H; Sakai Y; Hirata Y; Kugiyama K; Nagai R
    Clin Sci (Lond); 2007 Jun; 112(12):607-16. PubMed ID: 17263691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of cerebral infarction and improvement of neurological deficit by a Korean herbal medicine, modified Bo-Yang-Hwan-O-Tang.
    Choi Y; Kim SK; Choi IY; Ju C; Nam KW; Hwang S; Kim BW; Yoon MJ; Won MH; Park YK; Kim WK
    J Pharm Pharmacol; 2011 May; 63(5):695-706. PubMed ID: 21492172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4-loaded PLGA microspheres relieve cerebral ischemia/reperfusion injury and neurologic deficits through long-lasting bioactivity-mediated phosphorylated Akt/eNOS signaling in rats.
    Chien CT; Jou MJ; Cheng TY; Yang CH; Yu TY; Li PC
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1790-803. PubMed ID: 26058696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
    Liu XG; Feng YP
    Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New evidence of neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous administration.
    Berthet C; Castillo X; Magistretti PJ; Hirt L
    Cerebrovasc Dis; 2012; 34(5-6):329-35. PubMed ID: 23154656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
    Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.